Senior Research Associate, CMC Process Sciences jobs in United States
info-icon
This job has closed.
company-logo

Dyne Therapeutics · 3 weeks ago

Senior Research Associate, CMC Process Sciences

positionWaltham, MA
timeFull-time
remoteOnsite
seniorityMid, Senior Level
money$121K/yr - $121K/yr
date1+ years exp

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Senior Research Associate, CMC Process Sciences, will be responsible for internal process development of oligonucleotide conjugates and provide technical support for validation activities.

BiotechnologyHealth CareMedicalPharmaceutical
check
Growth Opportunities
check
H1B Sponsor Likelynote

Responsibilities

Drug substance process development, including bioconjugation chemistry, purification, and analytical development
Lead internal CMC Process Development activities via hands-on contribution in the lab
Partner with Research to support bioconjugation development activities and enhance the tech transfer process to external manufacturing partners
Represent CMC and Process Sciences as a technical leader in internal cross-functional teams
Establish clear expectations and priorities, set objectives, and effectively apply resources to deliver on program goals
Contribute creative ideas and new innovations that enable better products and processes

Qualification

Bioconjugation chemistryAnalytical techniquesProcess developmentPreparative chromatographyTechnical leadershipCollaborationCreative problem solving

Required

Master's degree or higher in pharmaceutical sciences, biochemistry, or chemistry, or a closely related field
1 year in Research & Development in a biopharmaceutical company. Experience must include:
(1 year) working with bioconjugates including demonstrating a deep understanding of conjugation chemistries, preparative chromatography, and TFF
(1 year) using analytical techniques for characterization of conjugates including HPLC/UPLC, SEC, SDS-PAGE, ion exchange chromatography, UV/vis, and LC-MS

Company

Dyne Therapeutics

twittertwittertwitter
company-logo
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
dateFounded in 2018
location
Cambridge, Massachusetts, USA
people-size51-200 employees
web-link
https://www.dyne-tx.com/

H1B Sponsorship

Dyne Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (7)
2023 (1)
2022 (3)
2021 (6)

Funding

Current Stage
Public Company
Total Funding
$1.67B
Key Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M

Leadership Team

leader-logo
John Cox
Chief Executive Officer
linkedin

Recent News

Labiotech UG
The biggest biotech funding rounds in December 2025
2026-01-11
GlobeNewswire
Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
2026-01-07
GlobeNewswire
Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
2025-12-24
Company data provided by crunchbase